Regeneron Pharmaceuticals net income 1990–2026What is an income statement? The income statement shows a company's revenue, costs and profit over a quarter or a year, from sales at the top to net income at the bottom.
Regeneron Pharmaceuticals earned 1.95B USD in Q3 FY2026, the three months to 30 September 2026, up 33.5% on the same quarter a year before. Regeneron Pharmaceuticals's net income over the last twelve months was 4.82B USD, up 5.2% on the twelve months before. In fiscal year 2025 it earned 4.50B USD, up 2.1% on the year before.
Last updated 6 Nov 2026 · Next report 28 Jan 2027
Net income
Growth
| Fiscal year | Period ending | Net income | Growth | Net margin | Revenue |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 4.82B | +5.23% | 28.51% | 16.90B |
| FY2025 | 31 Dec 2025 | 4.50B | +2.09% | 31.41% | 14.34B |
| FY2024 | 31 Dec 2024 | 4.41B | +11.61% | 31.07% | 14.20B |
| FY2023 | 31 Dec 2023 | 3.95B | -8.87% | 30.14% | 13.12B |
| FY2022 | 31 Dec 2022 | 4.34B | -46.28% | 35.64% | 12.17B |
| FY2021 | 31 Dec 2021 | 8.08B | +129.86% | 50.25% | 16.07B |
| FY2020 | 31 Dec 2020 | 3.51B | +66.05% | 41.35% | 8.50B |
| FY2019 | 31 Dec 2019 | 2.12B | -13.44% | 32.26% | 6.56B |
| FY2018 | 31 Dec 2018 | 2.44B | +103.95% | 36.42% | 6.71B |
| FY2017 | 31 Dec 2017 | 1.20B | +33.83% | 20.41% | 5.87B |
| FY2016 | 31 Dec 2016 | 895.52M | +40.79% | 18.42% | 4.86B |
| FY2015 | 31 Dec 2015 | 636.06M | +82.74% | 15.50% | 4.10B |
| FY2014 | 31 Dec 2014 | 348.07M | -17.98% | 12.34% | 2.82B |
| FY2013 | 31 Dec 2013 | 424.36M | -43.44% | 20.16% | 2.10B |
| FY2012 | 31 Dec 2012 | 750.27M | — | 54.43% | 1.38B |
| FY2011 | 31 Dec 2011 | -221.76M | — | -49.74% | 445.82M |
| FY2010 | 31 Dec 2010 | -104.47M | — | -22.76% | 459.07M |
| FY2009 | 31 Dec 2009 | -67.83M | — | -17.88% | 379.27M |
| FY2008 | 31 Dec 2008 | -82.71M | — | -34.69% | 238.46M |
| FY2007 | 31 Dec 2007 | -105.60M | — | -84.46% | 125.02M |
| FY2006 | 31 Dec 2006 | -102.34M | — | -161.30% | 63.45M |
| FY2005 | 31 Dec 2005 | -95.45M | -328.89% | -144.19% | 66.19M |
| FY2004 | 31 Dec 2004 | 41.70M | — | 23.96% | 174.02M |
| FY2003 | 31 Dec 2003 | -107.46M | — | -186.89% | 57.50M |
| FY2002 | 31 Dec 2002 | -124.38M | — | -565.66% | 21.99M |
| FY2001 | 31 Dec 2001 | -76.18M | — | -346.70% | 21.97M |
| FY2000 | 31 Dec 2000 | -23.22M | — | -39.16% | 59.28M |
| FY1999 | 31 Dec 1999 | -23.10M | — | -66.96% | 34.50M |
| FY1998 | 31 Dec 1998 | -8.60M | — | -22.51% | 38.20M |
| FY1997 | 31 Dec 1997 | -11.60M | — | -35.05% | 33.10M |
| FY1996 | 31 Dec 1996 | -32.40M | — | -134.44% | 24.10M |
| FY1995 | 31 Dec 1995 | -23.50M | — | -85.77% | 27.40M |
| FY1994 | 31 Dec 1994 | -30.70M | — | -132.33% | 23.20M |
| FY1993 | 31 Dec 1993 | -39.90M | — | -376.42% | 10.60M |
| FY1992 | 31 Dec 1992 | -19.10M | — | -166.09% | 11.50M |
| FY1991 | 31 Dec 1991 | -4.50M | — | -61.64% | 7.30M |
| FY1990 | 31 Dec 1990 | -3.30M | — | -66.00% | 5.00M |
| Quarter | Period ending | Net income | Growth on a year before | Net margin | Revenue |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 1.95B | +33.47% | 38.09% | 5.12B |
| Q2 FY2026 | 30 Jun 2026 | 1.30B | -6.81% | 30.23% | 4.29B |
| Q1 FY2026 | 31 Mar 2026 | 727.20M | -10.08% | 20.17% | 3.61B |
| Q4 FY2025 | 31 Dec 2025 | 844.60M | -7.97% | 21.74% | 3.88B |
| Q3 FY2025 | 30 Sept 2025 | 1.46B | +8.91% | 38.89% | 3.75B |
| Q2 FY2025 | 30 Jun 2025 | 1.39B | -2.84% | 37.86% | 3.68B |
| Q1 FY2025 | 31 Mar 2025 | 808.70M | +12.01% | 26.70% | 3.03B |
| Q4 FY2024 | 31 Dec 2024 | 917.70M | -20.86% | 24.22% | 3.79B |
| Q3 FY2024 | 30 Sept 2024 | 1.34B | +33.02% | 36.03% | 3.72B |
| Q2 FY2024 | 30 Jun 2024 | 1.43B | +47.90% | 40.38% | 3.55B |
| Q1 FY2024 | 31 Mar 2024 | 722.00M | -11.71% | 22.96% | 3.15B |
| Q4 FY2023 | 31 Dec 2023 | 1.16B | -3.13% | 33.77% | 3.43B |
| Q3 FY2023 | 30 Sept 2023 | 1.01B | -23.40% | 29.97% | 3.36B |
| Q2 FY2023 | 30 Jun 2023 | 968.40M | +13.65% | 30.66% | 3.16B |
| Q1 FY2023 | 31 Mar 2023 | 817.80M | -15.99% | 25.86% | 3.16B |
| Q4 FY2022 | 31 Dec 2022 | 1.20B | -46.29% | 35.06% | 3.41B |
| Q3 FY2022 | 30 Sept 2022 | 1.32B | -19.39% | 44.81% | 2.94B |
| Q2 FY2022 | 30 Jun 2022 | 852.10M | -72.50% | 29.82% | 2.86B |
| Q1 FY2022 | 31 Mar 2022 | 973.50M | -12.71% | 32.83% | 2.97B |
| Q4 FY2021 | 31 Dec 2021 | 2.23B | +93.96% | 45.01% | 4.95B |
| Q3 FY2021 | 30 Sept 2021 | 1.63B | +93.82% | 47.27% | 3.45B |
| Q2 FY2021 | 30 Jun 2021 | 3.10B | +245.36% | 60.31% | 5.14B |
| Q1 FY2021 | 31 Mar 2021 | 1.12B | +78.55% | 44.10% | 2.53B |
| Q4 FY2020 | 31 Dec 2020 | 1.15B | +45.10% | 47.43% | 2.42B |
| Q3 FY2020 | 30 Sept 2020 | 842.10M | +25.76% | 36.71% | 2.29B |
| Q2 FY2020 | 30 Jun 2020 | 897.30M | +364.68% | 45.97% | 1.95B |
| Q1 FY2020 | 31 Mar 2020 | 624.60M | +35.46% | 34.16% | 1.83B |
| Q4 FY2019 | 31 Dec 2019 | 792.00M | -3.46% | 42.50% | 1.86B |
| Q3 FY2019 | 30 Sept 2019 | 669.60M | +12.60% | 38.40% | 1.74B |
| Q2 FY2019 | 30 Jun 2019 | 193.10M | -64.98% | 12.24% | 1.58B |
| Q1 FY2019 | 31 Mar 2019 | 461.10M | -3.53% | 33.59% | 1.37B |
| Q4 FY2018 | 31 Dec 2018 | 820.40M | +372.80% | 42.56% | 1.93B |
| Q3 FY2018 | 30 Sept 2018 | 594.66M | +53.14% | 35.75% | 1.66B |
| Q2 FY2018 | 30 Jun 2018 | 551.41M | +42.21% | 34.29% | 1.61B |
| Q1 FY2018 | 31 Mar 2018 | 477.98M | +92.01% | 31.62% | 1.51B |
| Q4 FY2017 | 31 Dec 2017 | 173.52M | -31.45% | 10.97% | 1.58B |
| Q3 FY2017 | 30 Sept 2017 | 388.32M | +46.64% | 25.88% | 1.50B |
| Q2 FY2017 | 30 Jun 2017 | 387.74M | +97.61% | 26.38% | 1.47B |
| Q1 FY2017 | 31 Mar 2017 | 248.93M | +50.20% | 18.87% | 1.32B |
| Q4 FY2016 | 31 Dec 2016 | 253.12M | +63.31% | 20.63% | 1.23B |
| Q3 FY2016 | 30 Sept 2016 | 264.80M | +25.86% | 21.70% | 1.22B |
| Q2 FY2016 | 30 Jun 2016 | 196.22M | +0.81% | 16.18% | 1.21B |
| Q1 FY2016 | 31 Mar 2016 | 165.74M | +118.01% | 13.80% | 1.20B |
| Q4 FY2015 | 31 Dec 2015 | 154.99M | +40.68% | 14.12% | 1.10B |
| Q3 FY2015 | 30 Sept 2015 | 210.40M | +163.92% | 18.50% | 1.14B |
| Q2 FY2015 | 30 Jun 2015 | 194.64M | +109.89% | 19.49% | 998.62M |
| Q1 FY2015 | 31 Mar 2015 | 76.02M | +16.16% | 8.74% | 869.61M |
| Q4 FY2014 | 31 Dec 2014 | 110.18M | +13.81% | 13.73% | 802.33M |
| Q3 FY2014 | 30 Sept 2014 | 79.72M | -43.58% | 10.98% | 725.79M |
| Q2 FY2014 | 30 Jun 2014 | 92.74M | +6.13% | 13.93% | 665.70M |
| Q1 FY2014 | 31 Mar 2014 | 65.44M | -33.81% | 10.46% | 625.74M |
| Q4 FY2013 | 31 Dec 2013 | 96.81M | -79.42% | 15.86% | 610.41M |
| Q3 FY2013 | 30 Sept 2013 | 141.31M | -26.20% | 23.67% | 597.03M |
| Q2 FY2013 | 30 Jun 2013 | 87.38M | +13.86% | 19.09% | 457.64M |
| Q1 FY2013 | 31 Mar 2013 | 98.87M | +748.63% | 22.49% | 439.66M |
| Q4 FY2012 | 31 Dec 2012 | 470.41M | — | 113.46% | 414.60M |
| Q3 FY2012 | 30 Sept 2012 | 191.47M | — | 44.77% | 427.69M |
| Q2 FY2012 | 30 Jun 2012 | 76.74M | — | 25.21% | 304.40M |
| Q1 FY2012 | 31 Mar 2012 | 11.65M | — | 5.03% | 231.79M |
| Q4 FY2011 | 31 Dec 2011 | -53.44M | — | -43.46% | 122.98M |
| Q3 FY2011 | 30 Sept 2011 | -62.37M | — | -60.65% | 102.83M |
| Q2 FY2011 | 30 Jun 2011 | -62.51M | — | -57.98% | 107.81M |
| Q1 FY2011 | 31 Mar 2011 | -43.45M | — | -38.72% | 112.20M |
| Q4 FY2010 | 31 Dec 2010 | -14.60M | — | -10.92% | 133.68M |
| Q3 FY2010 | 30 Sept 2010 | -33.88M | — | -31.96% | 105.98M |
| Q2 FY2010 | 30 Jun 2010 | -25.47M | — | -21.98% | 115.89M |
| Q1 FY2010 | 31 Mar 2010 | -30.52M | — | -29.48% | 103.53M |
| Q4 FY2009 | 31 Dec 2009 | -36.49M | — | -37.70% | 96.80M |
| Q3 FY2009 | 30 Sept 2009 | -1.02M | — | -0.86% | 117.46M |
| Q2 FY2009 | 30 Jun 2009 | -14.94M | — | -16.59% | 90.03M |
| Q1 FY2009 | 31 Mar 2009 | -17.48M | — | -23.31% | 74.98M |
| Q4 FY2008 | 31 Dec 2008 | -31.52M | — | -56.45% | 55.84M |
| Q3 FY2008 | 30 Sept 2008 | -21.12M | — | -32.20% | 65.58M |
| Q2 FY2008 | 30 Jun 2008 | -18.46M | — | -30.43% | 60.65M |
| Q1 FY2008 | 31 Mar 2008 | -11.62M | — | -20.61% | 56.38M |
| Q4 FY2007 | 31 Dec 2007 | -13.07M | — | -20.19% | 64.73M |
| Q3 FY2007 | 30 Sept 2007 | -35.84M | — | -160.63% | 22.31M |
| Q2 FY2007 | 30 Jun 2007 | -26.77M | — | -120.63% | 22.20M |
| Q1 FY2007 | 31 Mar 2007 | -29.92M | — | -189.49% | 15.79M |
| Q4 FY2006 | 31 Dec 2006 | -30.97M | — | -299.35% | 10.35M |
| Q3 FY2006 | 30 Sept 2006 | -27.41M | — | -175.44% | 15.62M |
| Q2 FY2006 | 30 Jun 2006 | -23.58M | — | -122.42% | 19.26M |
| Q1 FY2006 | 31 Mar 2006 | -20.38M | — | -111.86% | 18.22M |
| Q4 FY2005 | 31 Dec 2005 | -29.67M | -1,162.75% | -170.29% | 17.42M |
| Q3 FY2005 | 30 Sept 2005 | -34.65M | — | -213.98% | 16.19M |
| Q2 FY2005 | 30 Jun 2005 | -27.00M | — | -164.97% | 16.37M |
| Q1 FY2005 | 31 Mar 2005 | -4.12M | -106.39% | -25.44% | 16.21M |
| Q4 FY2004 | 31 Dec 2004 | 2.79M | — | 5.93% | 47.09M |
| Q3 FY2004 | 30 Sept 2004 | -11.08M | — | -30.33% | 36.52M |
| Q2 FY2004 | 30 Jun 2004 | -14.55M | — | -51.20% | 28.42M |
| Q1 FY2004 | 31 Mar 2004 | 64.53M | — | 104.10% | 61.99M |
| Q4 FY2003 | 31 Dec 2003 | -19.38M | — | -91.09% | 21.27M |
| Q3 FY2003 | 30 Sept 2003 | -27.40M | — | -157.54% | 17.39M |
| Q2 FY2003 | 30 Jun 2003 | -28.74M | — | -272.84% | 10.53M |
| Q1 FY2003 | 31 Mar 2003 | -30.11M | — | -297.06% | 10.14M |
| Q4 FY2002 | 31 Dec 2002 | -35.69M | — | -726.65% | 4.91M |
| Q3 FY2002 | 30 Sept 2002 | -32.82M | — | -499.79% | 6.57M |
| Q2 FY2002 | 30 Jun 2002 | -30.42M | — | -546.29% | 5.57M |
| Q1 FY2002 | 31 Mar 2002 | -25.45M | — | -514.98% | 4.94M |
| Q4 FY2001 | 31 Dec 2001 | -28.38M | — | -644.81% | 4.40M |
| Q3 FY2001 | 30 Sept 2001 | -19.93M | — | -363.70% | 5.48M |
| Q2 FY2001 | 30 Jun 2001 | -14.83M | — | -256.69% | 5.78M |
| Q1 FY2001 | 31 Mar 2001 | -13.04M | — | -143.50% | 9.09M |
| Q4 FY2000 | 31 Dec 2000 | -9.74M | — | -50.16% | 19.42M |
| Q3 FY2000 | 30 Sept 2000 | -3.21M | — | -21.54% | 14.91M |
| Q2 FY2000 | 30 Jun 2000 | -2.95M | — | -20.39% | 14.46M |
| Q1 FY2000 | 31 Mar 2000 | -7.32M | — | -69.71% | 10.50M |
| Q4 FY1999 | 31 Dec 1999 | -1.40M | — | -11.76% | 11.90M |
| Q3 FY1999 | 30 Sept 1999 | -4.90M | — | -43.36% | 11.30M |
| Q2 FY1999 | 30 Jun 1999 | -7.80M | -471.43% | -132.20% | 5.90M |
| Q1 FY1999 | 31 Mar 1999 | -8.90M | — | -161.82% | 5.50M |
| Q4 FY1998 | 31 Dec 1998 | -5.50M | -1,200.00% | -74.32% | 7.40M |
| Q3 FY1998 | 30 Sept 1998 | -1.40M | — | -12.96% | 10.80M |
| Q2 FY1998 | 30 Jun 1998 | 2.10M | — | 15.56% | 13.50M |
| Q1 FY1998 | 31 Mar 1998 | -3.80M | — | -58.46% | 6.50M |
| Q4 FY1997 | 31 Dec 1997 | 500.00K | — | 4.39% | 11.40M |
| Q3 FY1997 | 30 Sept 1997 | -1.90M | — | -21.35% | 8.90M |
| Q2 FY1997 | 30 Jun 1997 | -4.30M | — | -65.15% | 6.60M |
| Q1 FY1997 | 31 Mar 1997 | -5.90M | — | -95.16% | 6.20M |
| Q4 FY1996 | 31 Dec 1996 | -8.10M | — | -124.62% | 6.50M |
| Q3 FY1996 | 30 Sept 1996 | -8.90M | — | -143.55% | 6.20M |
| Q2 FY1996 | 30 Jun 1996 | -7.60M | — | -122.58% | 6.20M |
| Q1 FY1996 | 31 Mar 1996 | -7.80M | — | -150.00% | 5.20M |
| Q4 FY1995 | 31 Dec 1995 | -7.80M | — | -134.48% | 5.80M |
| Q3 FY1995 | 30 Sept 1995 | -7.10M | — | -114.52% | 6.20M |
| Q2 FY1995 | 30 Jun 1995 | -4.40M | — | -57.89% | 7.60M |
| Q1 FY1995 | 31 Mar 1995 | -4.20M | — | -60.87% | 6.90M |
| Q4 FY1994 | 31 Dec 1994 | -5.80M | — | -75.32% | 7.70M |
| Q3 FY1994 | 30 Sept 1994 | -4.00M | — | -44.94% | 8.90M |
| Q2 FY1994 | 30 Jun 1994 | -10.20M | — | -283.33% | 3.60M |
| Q1 FY1994 | 31 Mar 1994 | -10.70M | — | -356.67% | 3.00M |
| Q4 FY1993 | 31 Dec 1993 | -11.50M | — | -396.55% | 2.90M |
| Q3 FY1993 | 30 Sept 1993 | -9.60M | — | -266.67% | 3.60M |
| Q2 FY1993 | 30 Jun 1993 | -9.40M | — | -723.08% | 1.30M |
| Q1 FY1993 | 31 Mar 1993 | -9.30M | — | -442.86% | 2.10M |
| Q4 FY1992 | 31 Dec 1992 | -6.40M | — | -278.26% | 2.30M |
| Q3 FY1992 | 30 Sept 1992 | -5.80M | — | -241.67% | 2.40M |
| Q2 FY1992 | 30 Jun 1992 | -3.70M | — | -115.63% | 3.20M |
| Q1 FY1992 | 31 Mar 1992 | -3.30M | — | -94.29% | 3.50M |
| Q4 FY1991 | 31 Dec 1991 | -2.10M | — | -105.00% | 2.00M |
| Q3 FY1991 | 30 Sept 1991 | -900.00K | — | -47.37% | 1.90M |
| Q2 FY1991 | 30 Jun 1991 | -300.00K | — | -17.65% | 1.70M |
| Q1 FY1991 | 31 Mar 1991 | -1.10M | — | -55.00% | 2.00M |
| Q4 FY1990 | 31 Dec 1990 | -900.00K | — | -69.23% | 1.30M |
| Q3 FY1990 | 30 Sept 1990 | -800.00K | — | -61.54% | 1.30M |
| Q2 FY1990 | 30 Jun 1990 | -800.00K | — | -66.67% | 1.20M |
| Q1 FY1990 | 31 Mar 1990 | -800.00K | — | -66.67% | 1.20M |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Regeneron Pharmaceuticals's profit
Source: Financial Modeling Prep
